Patients, Purpose & Ethics of Progress
Update: 2025-10-14
Description
In this episode, Tom Caravela is joined by Kirk Shepherd to explore the importance of patient voices in clinical decision-making, addressing access, equity, and diversity in oncology. They discuss balancing corporate pressures with a sense of purpose, and how patient feedback can shape clinical outcomes. The episode examines the evolving role of patients in clinical research and anticipated changes in oncology innovation, including technological advancements affecting participation. Ethical progress in the field is emphasized, concluding with thoughts on legacy in medical affairs and closing remarks.
(0:00 ) Introduction and background of Kirk Shepherd
(1:42 ) Transition and career overview in the pharmaceutical industry
(5:06 ) Sponsor: Oncology Voice Network
(7:18 ) Launch and impact of "Voices of Oncology"
(8:20 ) Patient voices in clinical decision-making and ethical considerations
(13:22 ) Tackling access, equity, and diversity in oncology
(17:46 ) Balancing purpose and corporate pressures in the industry
(19:29 ) Patient feedback shaping clinical outcomes
(23:49 ) The evolving role of patients in clinical research
(25:17 ) Anticipated changes in patient involvement and oncology innovation
(29:03 ) Technological advancements affecting patient participation
(29:45 ) Ensuring ethical progress in the oncology field
(31:34 ) Concluding thoughts on legacy in medical affairs
(31:40 ) Closing remarks and sponsor mentions
(0:00 ) Introduction and background of Kirk Shepherd
(1:42 ) Transition and career overview in the pharmaceutical industry
(5:06 ) Sponsor: Oncology Voice Network
(7:18 ) Launch and impact of "Voices of Oncology"
(8:20 ) Patient voices in clinical decision-making and ethical considerations
(13:22 ) Tackling access, equity, and diversity in oncology
(17:46 ) Balancing purpose and corporate pressures in the industry
(19:29 ) Patient feedback shaping clinical outcomes
(23:49 ) The evolving role of patients in clinical research
(25:17 ) Anticipated changes in patient involvement and oncology innovation
(29:03 ) Technological advancements affecting patient participation
(29:45 ) Ensuring ethical progress in the oncology field
(31:34 ) Concluding thoughts on legacy in medical affairs
(31:40 ) Closing remarks and sponsor mentions
Comments
In Channel